Abiopharma

Receipt of an order for the purchase of cameras and products in the amount of $5.6 million, to be supplied by the end of the fourth quarter of 2026

Receipt of purchase order of cameras and accessories, for a total consideration of approximately USD 5.6 million

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Dormant shares – creation of dormant shares

Ceased to be an interested party - Mor Multi Strategies - Limited Partnership

Ceased to be an interested party - Harel Insurance Investments and Financial Services Ltd.

Other Report or Announcement

AKVA group ASA: Q2 2026 financial reporting

Diversified Energy Response to Media Speculation